This cohort study explores the role of human papillomavirus status in patients with head and neck squamous cell cancer, stratified by race/ethnicity, sex, and oropharyngeal squamous cell carcinoma vs nonoropharyngeal head and neck squamous cell carcinoma.
This population-based study of patients with head and neck cancer investigates whether immunologic response to human papillomavirus 16 is associated with patient survival across anatomic sites, independent of smoking and drinking history.
This cohort study investigates the association between adjuvant tamoxifen and aromatase inhibitor therapy and contralateral breast cancer risk.
This secondary analysis of the CRYSTAL and FIRE-3 trials examines the prognostic and predictive value of primary tumor location in patients with metastatic colorectal cancer treated with fluorouracil, leucovorin, and irinotecan plus cetuximab.
This genetic-clinical correlation study assesses the prognostic power of the genetic duet of BRAF V600E and TERT promoter mutations in papillary thyroid cancer–specific mortality.
This systematic review and meta-analysis examines the prognostic value of primary tumor sidedness (right vs left) in colon cancer.
This randomized clinical trial of patients with locoregionally advanced squamous cell carcinoma of the head and neck compared the effect of accelerated-fractionation radiotherapy (RT) plus the anti–epidermal growth factor receptor antibody panitumumab vs standard-fractionation RT plus high-dose cisplatin on progression-free survival.
This secondary analysis of the NeoALTTO trial uses RNA sequencing data to investigate the ability of clinically and biologically relevant genes and gene signatures to predict the efficacy of anti-HER2 agents.
This analysis of findings of a randomized, double-blind, phase 3 trial assesses treatment effects and tolerability of ramucirumab by Child-Pugh score in patients with hepatocellular cancer enrolled from 154 global sites.
This study examines the distinct biology of recurrent and metastatic head and neck cancers and reviews implementation of precision oncology for patients with advanced disease.
This clinical pathology study evaluates whether 4 commercially available drug-matched companion diagnostic PD-L1 antibody tests produce the same results when tested against lung cancer specimens with known range of expression of PD-L1.
This study describes the ocular toxic effects of 3 different mitogen-activated protein kinase inhibitors currently at independent stages of clinical development.
This study examines 5-year trends in Medicare data and compares prices for older cancer drugs with prices for newer cancer drugs.
This narrative review summarizes the current state of genomic testing for somatic mutations in breast cancer and considers approaches for more effective implementation.
A woman in her 70s presented with progressive supraclavicular, facial, and mandibular swelling of 3 months’ duration; a fixed mass throughout the left preauricular space; and a right supraclavicular mass. What is your diagnosis?
This Viewpoint highlights recent findings in noncolorectal gastrointestinal cancer treatments.
This Viewpoint highlights ASCO presentations of recent findings in studies of metastatic non–small cell lung cancer.
This randomized trial assessed whether patients with 1 to 3 brain metastases who received stereotactic radiosurgery (SRS) alone vs SRS combined with whole brain radiotherapy (WBRT) had less cognitive deterioration at 3 months.
Create a personal account or sign in to: